UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 4)
Omega Healthcare Investors, Inc.
-------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.10 per share
-------------------------------------------------------------
(Title of Class of Securities)
681936100
-------------------------------------
(CUSIP Number)
William T. Cavanaugh, Jr.
Explorer Holdings, L.P.
2200 Ross Avenue
Suite 4200 West
Dallas, Texas 75201-6799
-------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
November 26, 2001
-------------------------------------
(Date of Event which Requires Filing of this Statement)
If the reporting person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
------------------------------------------- -------------------
CUSIP NO. 681936100 13D Page 2 of 9 Pages
------------------------------------------- -------------------
-------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Explorer Holdings, L.P.
-------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) / /
-------------------------------------------------------------------------------
(3) SEC USE ONLY
-------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC
-------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) / /
-------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY OWNED None
BY EACH REPORTING --------------------------------------------------
PERSON WITH (8) SHARED VOTING POWER
17,328,570**
--------------------------------------------------
(9) SOLE DISPOSITIVE POWER
None
--------------------------------------------------
(10) SHARED DISPOSITIVE POWER
17,328,570**
-------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,328,570**
-------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / /*
-------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
47.0%**
-------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
PN
-------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
**The Reporting Person beneficially owns 553,850 shares of common stock and
1,048,420 shares of Series C Convertible Preferred Stock, which Series C shares
are convertible into 16,774,720 shares of common stock of Omega. Based on the
number of shares of common stock of Omega reported to be outstanding as of
October 26, 2001, all such shares would represent 47.0% of Omega's outstanding
shares of common stock as of October 26, 2001, after giving effect to such
issuance. Pursuant to the Investment Agreement described in Items 3 and 4 of
Amendment No. 3 to this Schedule 13D/A, Explorer Holdings, L.P. has agreed to
purchase additional shares of stock of Omega in an amount equal to the
difference between $50 million and the gross proceeds received by Omega from the
sale of common stock in a rights offering that Omega has agreed to commence
promptly after the date hereof. If the stockholders of Omega approve the
issuance of common stock to Explorer prior to the closing of the transactions
contemplated by the Investment Agreement, Explorer will purchase shares of
common stock; otherwise, the purchased shares will consist of Series D
Convertible Preferred Stock having the terms described in Item 3 of Amendment
No. 3 to this Schedule 13D/A. The purchase price for the shares to be acquired
by Explorer (or the per common share conversion price, if the purchased shares
are Series D Preferred) will be the same price as the subscription price offered
to Omega's stockholders in the rights offering, not to exceed $2.92 per share.
Because the number of shares to be acquired by Explorer will depend upon the
number of shares subscribed for in the rights offering, it is not possible to
determine at this time the number of shares that will be acquired by Explorer
pursuant to the Investment Agreement.
------------------------------------------- -------------------
CUSIP NO. 681936100 13D Page 3 of 9 Pages
------------------------------------------- -------------------
-------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Explorer Holdings GenPar, LLC
-------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) / /
-------------------------------------------------------------------------------
(3) SEC USE ONLY
-------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC
-------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) / /
-------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY OWNED None
BY EACH REPORTING --------------------------------------------------
PERSON WITH (8) SHARED VOTING POWER
17,328,570**
--------------------------------------------------
(9) SOLE DISPOSITIVE POWER
None
--------------------------------------------------
(10) SHARED DISPOSITIVE POWER
17,328,570**
-------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,328,570**
-------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / /*
-------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
47.0%**
-------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
00
-------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
------------------------------------------- -------------------
CUSIP NO. 681936100 13D Page 4 of 9 Pages
------------------------------------------- -------------------
-------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Hampstead Investment Partners III, L.P.
-------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) / /
-------------------------------------------------------------------------------
(3) SEC USE ONLY
-------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC
-------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) / /
-------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
-------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY OWNED None
BY EACH REPORTING --------------------------------------------------
PERSON WITH (8) SHARED VOTING POWER
17,328,570**
--------------------------------------------------
(9) SOLE DISPOSITIVE POWER
None
--------------------------------------------------
(10) SHARED DISPOSITIVE POWER
17,328,570**
-------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,328,570**
-------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / /*
-------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
47.0%**
-------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
PN
-------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
------------------------------------------- -------------------
CUSIP NO. 681936100 13D Page 5 of 9 Pages
------------------------------------------- -------------------
-------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Donald J. McNamara
-------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) / /
-------------------------------------------------------------------------------
(3) SEC USE ONLY
-------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC
-------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) / /
-------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
-------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY OWNED None
BY EACH REPORTING --------------------------------------------------
PERSON WITH (8) SHARED VOTING POWER
17,328,570**
--------------------------------------------------
(9) SOLE DISPOSITIVE POWER
None
--------------------------------------------------
(10) SHARED DISPOSITIVE POWER
17,328,570**
-------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,328,570**
-------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / /*
-------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
47.0%**
-------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
-------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
------------------------------------------- -------------------
CUSIP NO. 681936100 13D Page 6 of 9 Pages
------------------------------------------- -------------------
-------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Daniel A. Decker
-------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) / /
-------------------------------------------------------------------------------
(3) SEC USE ONLY
-------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC
-------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) / /
-------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
-------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY OWNED None
BY EACH REPORTING --------------------------------------------------
PERSON WITH (8) SHARED VOTING POWER
17,328,570**
--------------------------------------------------
(9) SOLE DISPOSITIVE POWER
None
--------------------------------------------------
(10) SHARED DISPOSITIVE POWER
17,328,570**
-------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,328,570**
-------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / /*
-------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
47.0%**
-------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
-------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
This amendment amends and supplements the information set forth in the
Statement on Schedule 13D filed on May 25, 2000, as amended on April 19, 2001,
September 20, 2001 and October 29, 2001 (as amended, the "STATEMENt") by the
Reporting Persons.
ITEM 1. SECURITY AND ISSUER.
This amendment relates to the common stock, par value $0.10 (the "COMMON
STOCK"), of Omega Healthcare Investors, Inc. (the "COMPANY") and the Series C
Convertible Preferred Stock, par value $1.00, of the Company (the "SERIES C
PREFERRED").
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item 3 is hereby amended to add the following at the end thereof:
The Reporting Persons have purchased 553,850 shares of Common Stock in
seven separate transactions. The source of funds for the Reporting Persons'
purchase of the 553,850 shares was the Reporting Persons' working capital, which
was derived from capital contributions from its partners.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5(a) is hereby amended to read in its entirety as follows:
(a) Each of the Reporting Persons beneficially owns 17,328,570 shares of
Common Stock, an amount which includes 16,774,720 shares of Common Stock owned
by virtue of Explorer's ownership of 1,048,420 shares of Series C Preferred.
Based on the number of shares of Common Stock reported to be outstanding as of
October 26, 2001, such shares would represent 47.0% of the Company's outstanding
shares of Common Stock as of October 26, 2001, after giving effect to such
issuance. The number of Shares that Explorer will purchase upon the closing of
the transactions contemplated by the Investment Agreement will depend upon the
price of the shares offered in the rights offering and the number of shares of
Common Stock purchased by the Company's stockholders pursuant to the rights
offering. Explorer will beneficially own such Shares directly and each of the
other Reporting Persons will beneficially own such Shares indirectly through the
relationships described in the Statement. Messrs. McNamara and Decker disclaim
beneficial ownership of all shares held by Explorer.
Item 5(c) is hereby amended to read in its entirety as follows:
(c) Each of the Reporting Persons has engaged in the following
transactions on the New York Stock Exchange since the date of the last amendment
to this Schedule 13D:
TRADE DATE NUMBER OF SHARES PURCHASED PRICE
---------- -------------------------- -----
11/19/2001 63,450 $3.55
11/20/2001 58,400 3.71
11/23/2001 50,700 3.94
11/24/2001 152,100 3.99
11/25/2001 3,900 3.98
11/26/2001 17,300 3.99
11/27/2001 208,000 4.12
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct, and agree that this Statement may be filed collectively on
behalf of each of the undersigned by Explorer Holdings, L.P., Explorer Holdings
GenPar, LLC, Hampstead Investment Partners III, L.P., Donald J. McNamara and
Daniel A. Decker.
Date: November 28, 2001 EXPLORER HOLDINGS, L.P.
By: Explorer Holdings GenPar, LLC,
its General Partner
By: /s/ William T. Cavanaugh, Jr.
-----------------------------
William T. Cavanaugh, Jr.
Authorized Officer
EXPLORER HOLDINGS GENPAR, LLC
By: /s/ William T. Cavanaugh, Jr.
-----------------------------
William T. Cavanaugh, Jr.
Authorized Officer
HAMPSTEAD INVESTMENT PARTNERS III, L.P.
By: Hampstead Investment Partners III
GenPar, L.P., its General Partner
By: Hampstead GenPar III, LLC,
its General Partner
By: /s/ William T. Cavanaugh, Jr.
-----------------------------
William T. Cavanaugh, Jr.
Authorized Officer
/s/ William T. Cavanaugh, Jr.*
------------------------------
Donald J. McNamara
/s/ William T. Cavanaugh, Jr.*
------------------------------
Daniel A. Decker
---------
* Pursuant to Power of Attorney previously filed.